The effect of intravenously administered 6063, the carbonic anhydrase inhibitor, 2-acetylamino-1, 3, 4-thiadiazole-5-sulfonamide, on fluid and electrolytes in normal subjects and patients with congestive heart failure.
D001826:Body Fluids; D002257:Carbonic Anhydrase Inhibitors; D004573:Electrolytes / Q000378:metabolism*; D006333:Heart Failure / Q000378:metabolism*; D006801:Humans; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides; D013830:Thiadiazoles
D002257:Carbonic Anhydrase Inhibitors; D004573:Electrolytes; D013424:Sulfanilamides; D013449:Sulfonamides; D013830:Thiadiazoles; D000077145:Sulfanilamide
CONGESTIVE HEART FAILURE/metabolism in; ELECTROLYTES/metabolism; SULFONAMIDES